Expert Side Effect Comparison: Which Is Right for You?
Understanding Wegovy Side Effects Compared to Mounjaro Mechanisms
When evaluating Wegovy side effects compared to Mounjaro, the fundamental difference lies in their mechanisms of action. Wegovy contains semaglutide, a selective GLP-1 receptor agonist that mimics your body's natural incretin hormone to reduce appetite and slow gastric emptying. Mounjaro uses tirzepatide, a dual receptor agonist targeting both GIP and GLP-1 pathways, potentially offering broader metabolic effects but also different side effect patterns.
The most common side effects for both treatments include gastrointestinal symptoms such as nausea, vomiting, diarrhoea, and constipation. However, clinical trials suggest that Mounjaro's dual mechanism may lead to slightly higher rates of gastrointestinal side effects during initial dose escalation compared to Wegovy's single-pathway approach. Both medications require careful dose titration to minimise side effects, with Wegovy escalating from 0.25mg to 2.4mg over 16 weeks, whilst Mounjaro follows a different schedule from 2.5mg to 15mg maximum dose.
Wegovy vs Mounjaro Pricing and Value Comparison
Understanding the cost implications when weighing Wegovy side effects compared to Mounjaro helps inform your treatment decision. Wegovy pricing starts at £79.99 for the 0.25mg starter dose, progressing to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 for the 2.4mg maintenance dose. Our Getting Started bundles like the Intro Duo (0.25mg & 0.5mg) cost £169.99, providing two months of initial treatment with code FIRST40 applied at checkout.
Mounjaro follows a different dosing structure with six available strengths, each requiring individual pricing assessment based on your prescribed dose. EverydayMeds offers both treatments through the same streamlined process, allowing your prescriber to recommend the most suitable option based on your medical history, side effect tolerance, and treatment goals. Returning customers can use code DOSE25 at checkout, whilst our 3-pen Ultimate Stability Trio (2.4mg) provides three months of Wegovy maintenance for £649.99.
Clinical Evidence for Wegovy Side Effects Compared to Mounjaro Trials
The STEP trial programme for Wegovy, including the landmark study by Wilding et al. published in NEJM 2021, demonstrated that gastrointestinal side effects were the most frequently reported adverse events. In clinical trials, patients taking Wegovy alongside diet and exercise experienced nausea in approximately 44% of cases, with most symptoms being mild to moderate and decreasing over time. The systematic dose escalation protocol was specifically designed to improve tolerability compared to starting at higher doses.
Mounjaro's clinical trials (SURMOUNT programme) showed similar gastrointestinal side effect patterns, though direct comparison isn't possible due to different trial designs, patient populations, and endpoints. Both treatments demonstrated that side effects typically peaked during dose escalation phases and improved with continued treatment. Your prescriber at EverydayMeds can review these clinical profiles alongside your individual medical history to determine which treatment's side effect profile may be better suited to your circumstances.
How Wegovy Works to Minimise Side Effects
Wegovy functions as a GLP-1 receptor agonist, mimicking your body's natural glucagon-like peptide-1 hormone to reduce appetite and promote satiety after smaller meals. This mechanism works primarily in your brain's appetite centres and digestive system, slowing gastric emptying to help you feel fuller for longer periods. The once-weekly injection schedule using the FlexTouch pen helps maintain consistent blood levels, reducing the peak-and-trough effects that can contribute to side effects with more frequent dosing. Side effects often correlate with the rate of dose escalation, which is why Wegovy follows a carefully structured 16-week titration schedule from 0.25mg to 2.4mg. This gradual increase allows your body to adapt to the medication's effects, significantly reducing the likelihood and severity of gastrointestinal symptoms compared to starting at therapeutic doses.
Streamlined Ordering Process for Both Wegovy and Mounjaro
EverydayMeds simplifies the process of accessing either treatment through our comprehensive online platform, starting with a 3-minute clinical assessment that evaluates your medical history, current medications, and treatment goals. Our qualified prescribers review your application within 3 working days (express 24-hour service available), considering factors like previous medication tolerance, comorbidities, and your preference when weighing Wegovy side effects compared to Mounjaro options. Once approved, your prescription-only medicine is dispatched via next-day delivery using cold-chain, temperature-controlled packaging to ensure medication integrity. Our GPhC-registered pharmacy (#9012878) maintains rigorous quality standards throughout the supply chain, from prescription verification through to doorstep delivery. The entire process is designed for convenience whilst maintaining clinical safety, with ongoing support available through our clinical team for any questions about side effects or treatment adjustments.
Storage and Practical Considerations: Wegovy vs Mounjaro
Storage requirements represent a key practical difference when evaluating Wegovy side effects compared to Mounjaro beyond clinical considerations. Wegovy offers a significant storage advantage, remaining stable at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both medications require initial storage between 2-8°C in your refrigerator, but Wegovy's extended room temperature stability makes it more suitable for travel, business trips, or situations where refrigeration access may be limited. The FlexTouch pen system used for Wegovy provides precise, reliable dosing with a simple injection technique that most patients master within their first few uses. Dose escalation timing is crucial for both treatments to minimise side effects, with Wegovy following a standardised schedule that your prescriber will explain during the consultation process, ensuring you understand when and how to progress through each dose strength safely.
Side Effect Management Strategies: Wegovy Compared to Mounjaro
Managing side effects effectively requires understanding the distinct profiles when comparing Wegovy side effects to Mounjaro across different patient populations. Wegovy's single GLP-1 pathway typically produces predictable gastrointestinal effects that follow a consistent pattern during dose escalation, making side effect management more straightforward for both patients and prescribers. Eating smaller, more frequent meals, avoiding high-fat foods, and staying well-hydrated can significantly reduce nausea and digestive discomfort with either treatment.
Mounjaro's dual mechanism may require different management approaches due to its broader metabolic effects, though both treatments benefit from similar dietary modifications and gradual dose progression. Your EverydayMeds prescriber can provide detailed guidance on managing specific side effects, including when to consider dose adjustments, temporary treatment pauses, or alternative approaches if initial tolerance is challenging. The key advantage of accessing both treatments through EverydayMeds is the continuity of care – if one treatment doesn't suit your side effect tolerance, switching to the alternative can be managed seamlessly through the same clinical team.
Making Your Decision: Expert Guidance on Wegovy vs Mounjaro
Both Wegovy and Mounjaro are available from EverydayMeds, ensuring you have access to expert comparison guidance rather than being limited to a single treatment option. Your prescriber can help determine which treatment's side effect profile aligns better with your medical history, lifestyle requirements, and treatment goals during the comprehensive clinical assessment. Starting your journey with either treatment begins with completing our online consultation, using discount code FIRST40 for new customers or DOSE25 for returning patients, followed by expert prescriber review and next-day cold-chain delivery once approved. Our GPhC-registered pharmacy (#9012878) provides ongoing clinical support throughout your treatment journey, whether you choose Wegovy's proven single-pathway approach or require evaluation for Mounjaro's dual-mechanism alternative. Visit https://everydaymeds.co.uk/collections/weight-loss to begin your personalised assessment and receive expert guidance on which prescription-only medicine may be most suitable for your individual circumstances.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
